Development of mucus-penetrating antibiotic and quorum sensing inhibitor nanoparticle complex for bronchiectasis therapy
Bronchiectasis is a chronic respiratory disease characterized by permanent and irreversible dilatation of the airways caused by a vicious cycle of infection and inflammation, leading to the loss of lung function, morbidity, and mortality. Early results suggested inhaled ciprofloxacin (CIP) as a prom...
محفوظ في:
المؤلف الرئيسي: | Tran, The Thien |
---|---|
مؤلفون آخرون: | Kunn Hadinoto Ong |
التنسيق: | Thesis-Doctor of Philosophy |
اللغة: | English |
منشور في: |
Nanyang Technological University
2020
|
الموضوعات: | |
الوصول للمادة أونلاين: | https://hdl.handle.net/10356/145374 |
الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
المؤسسة: | Nanyang Technological University |
اللغة: | English |
مواد مشابهة
-
A potential quorum-sensing inhibitor for bronchiectasis therapy: quercetin–chitosan nanoparticle complex exhibiting superior inhibition of biofilm formation and swimming motility of Pseudomonas aeruginosa to the native quercetin
بواسطة: Tran, The-Thien, وآخرون
منشور في: (2021) -
Ternary nanoparticle complex of antibiotic, polyelectrolyte, and mucolytic enzyme as a potential antibiotic delivery system in bronchiectasis therapy
بواسطة: Tran, The-Thien, وآخرون
منشور في: (2022) -
Development of inhalable antimicrobial nanoparticle complex
بواسطة: Yu, Hong
منشور في: (2018) -
An evaluation of inhaled antibiotic liposome versus antibiotic nanoplex in controlling infection in bronchiectasis
بواسطة: Tran, The-Thien, وآخرون
منشور في: (2020) -
Engineered antibiotic nanoparticles for inhaled anti-biofilm therapy
بواسطة: Cheow, Wean Sin
منشور في: (2012)